Salute e Benessere

Global Theranostics Market to Triple, Reaching $12.7 Billion by 2029

The theranostics market is robust and dynamic, characterized by a diverse array of companies offering comprehensive solutions. Major players in the market, including leaders in diagnostics and therapeutics, are profiled extensively, detailing their revenues, product portfolios, and recent strategic initiatives. The competitive landscape is thoroughly examined alongside market trends and key dynamics such as drivers, restraints, and opportunities. Segmented by product type, theranostics offerings…
PR Newswire
26/09/2024

LiveWell Awarded Frost & Sullivan's 2024 Global Customer Value Leadership Award…

In their report, Frost & Sullivan state that LiveWell provides world-class digital health and well-being solutions to balance physical, mental, social, and financial health through its user-friendly app. LiveWell offers a wide range of tools that include mood and stress tracking; mental health support; and services offering support on a range of wellness topics. LiveWell is one of many pioneers addressing significant challenges to the mental and behavioral health industry, such as stigma…
PR Newswire
26/09/2024

Minovia Therapeutics Announces FDA Clearance of IND Application for a Phase Ib…

MNV-201 is a mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria In pre-clinical studies, MNV-201 demonstrated improved engraftment and bone marrow reconstitution potential of patient derived hematopoietic stem cellsIn vitro data also demonstrated improved ability to differentiate to erythroid cells, supporting potential for improvement in biomarkers of anemiaHAIFA, Israel, Sept.26, 2024...
Nasdaq GlobeNewswire
26/09/2024

OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate…

OSE Immunotherapeutics Announces Historic H1 2024 Results andProvides Corporate Update Financial and business highlightsTotal H1 2024 incomes of €82.5 million thanks to Company's new partnerships.New strategic partnership with AbbVie for up to $713 million, including $48 million received upon signature.Major partnership expansion with Boehringer Ingelheim: Amendment of the collaboration and licensing agreement on first-in-class SIRPα compounds developed both in...
Nasdaq GlobeNewswire
26/09/2024

Vistin Pharma ASA: Mandatory notification of trade

Saga Pure ASA has on 26 September 2024 purchased 50,000 shares in Vistin Pharma ASA at NOK 28.2 per share. After the transaction Saga Pure ASA has a holding of 700,000 shares, corresponding to 1.58% ownership.Saga Pure ASA is closely associated with board member Øystein Stray Spetalen. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment 20240926_Notification of trade_Saga i Vistin
Nasdaq GlobeNewswire
26/09/2024

Medical Gas and Equipment Market to Hit USD 26.44 Billion by 2029 with 5.8% CAGR…

Browse in-depth TOC on "Medical Gas and Equipment Market" Browse in-depth TOC on "Medical Gas and Equipment Market" 394 - Tables 60 - Figures 380 - Pages By type, the medical gas and equipment market is segmented into medical gases and medical gas equipment. In 2023, the medical gas segment accounted for the largest share in the medical gas and equipment market due to the essential role of gases in various medical applications, including anesthesia, respiratory therapy…
PR Newswire
26/09/2024

AbZelectPRO™ enables biopharma customers to reach their research cell bank in 10…

Simon Keen, VP of Cell Line Development at Abzena, states: "Our goal with AbZelectPRO™ was to offer our customers a strong cell line development platform with shorter timelines, higher production levels and lower production costs. When we launched the platform in January 2024, we were utilizing data from initial research and development projects. Over the past 10 months we've been fine-tuning the platform, generating more data from real-world projects, which has allowed us to showcase its…
PR Newswire
26/09/2024

Bavarian Nordic Upgrades its Financial Guidance for 2024

COPENHAGEN, Denmark, September 26, 2024– Bavarian Nordic A/S (OMX: BAVA) upgrades its financial guidance for 2024.Based on today's announced mpox vaccine order and additional orders secured, combined with improved performance in Travel Health, as well as other parts of the business, Bavarian Nordic now expects revenue between DKK 5,400 million and DKK 5,800 million and EBITDA between DKK 1,450 million and DKK 1,700 million.Revenue from the Travel Health business is now expected at...
Nasdaq GlobeNewswire
26/09/2024

Bavarian Nordic Signs Agreement with UNICEF for 1 Million Mpox Vaccines

First award under UNICEF emergency tender to secure availability of mpox vaccines for AfricaCOPENHAGEN, Denmark, September 26, 2024– Bavarian Nordic A/S (OMX: BAVA) today announced an agreement with UNICEF for the supply of 1 million doses of the MVA-BN ®mpox vaccine for countries in Africa impacted by the mpox outbreak.Under the agreement, UNICEF will procure 1 million doses of the vaccine which includes the 500,000 doses that were committed by Gavi and announced on September...
Nasdaq GlobeNewswire
26/09/2024

Cleanroom Technologies Market to Hit USD 12.3 Billion by 2029 with 6.9% CAGR |…

Browse in-depth TOC on "Cleanroom Technologies Market" Browse in-depth TOC on "Cleanroom Technologies Market" 350 - Tables 280 - Figures 400 - Pages Based on Type, the cleanroom technologies market has been segmented into standard cleanrooms, modular cleanrooms and mobile cleanrooms. The modular cleanroom is further segmented into hardwall cleanrooms and softwall cleanrooms. The modular cleanrooms segment accounted for the largest share of the cleanroom technologies market...
PR Newswire
26/09/2024

Urteste Expands Development of Innovative Diagnostic Projects

Urteste Expands Development of Innovative Diagnostic ProjectsGdańsk, Poland – 26 SEPTEMBER 2024, 16:00 CET - Urteste S.A. (Warsaw Stock Exchange: URT), a biotechnology company specializing in the development of breakthrough technology to detect cancer from urine samples, best known for its flagship project PANURI, a diagnostic test for pancreatic cancer. The company's breakthrough technology allows for early detection of cancer by measuring the activity of enzymes present...
Nasdaq GlobeNewswire
26/09/2024

Infectious Disease Therapeutics Market Surges to USD 140.71 Billion by 2030…

Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=817164 Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=817164 Browse in-depth TOC onInfectious Disease Therapeutics Market 202 - Pages 126 – Tables 37 – Figures Scope of The Report Global Infectious Disease Therapeutics Market Overview Market Drivers Fueling Growth in the Infectious Disease Therapeutics Market Rising Prevalence of Infectious...
PR Newswire
26/09/2024

Coronado Research announce appointment of Gail Kniveton to Chief Talent Officer…

Kniveton commented, "I am delighted to be joining an organisation that places employee needs at the top of the agenda. I have always focussed my work on businesses with high innovation, looking to change working practices and finding "unicorn people" to lead them. Coronado Research aligns perfectly with my passion for creating high performing, high innovation teams. We already have a great team lined up and I look forward to bringing them into Coronado over the coming months and…
PR Newswire
26/09/2024

ZEISS reinvents lens extraction with the first hand-held ultrasound-free lens…

"We're putting the future of lens extraction in the hands of surgeons today," says Euan S. Thomson, Ph.D., President of Ophthalmology Strategic Business Unit and Head of the Digital Business Unit for ZEISS Medical Technology. "The ZEISS MICOR 700 extends our cataract solutions portfolio and serves as a testament to ZEISS's ability to deliver revolutionary, state-of-the-art technologies that advance cataract surgery, benefiting both patients and surgeons." "We're putting…
PR Newswire
26/09/2024

Wyoming Medicaid Becomes First State to Cover Cognoa's Canvas Dx, Expanding…

In Wyoming, as in many states, autism remains under-detected. The average age of diagnosis is 6.1 years – over a year later than the U.S. average of 5 years, and more than 4.5 years after a reliable diagnosis is generally possible, at 18 months. Families in Wyoming travel up to 224 miles for an autism evaluation, creating additional barriers to timely diagnosis and intervention and underscoring the scarcity of services. InWyoming, as in many states, autism remains under-detected. The average...
PR Newswire
26/09/2024

Global Health Exhibition to Showcase Unique Advances in AI-Enabled Diagnostics…

"We are in a transformative era in radiology, where artificial intelligence and now Gen AI is redefining the entire patient experience, from enhancing diagnostic accuracy to improving safety. This paradigm shift in healthcare allows for personalised and more precise treatment options," said Global Health Exhibition panellist Dr. Maha Gmira, Chief Technology Officer of SolutionAI. "We are in a transformative era in radiology, where artificial intelligence and now Gen AI is…
PR Newswire
26/09/2024

SciBase expands to new market in Pennsylvania and receives first order from…

"We are thrilled to commence a partnership with Seraly Dermatology Their focus on individual patient care is one of many reasons we are proud to partner with them. I'm also pleased to see that our recent U.S. team expansion is already having a positive impact on the U.S. market by increasing access of the Nevisense test to more patients in new geographic areas", says Pia Renaudin, CEO of SciBase. " We are thrilled to commence a partnership with Seraly Dermatology Their focus on…
PR Newswire
26/09/2024

Study Finds Lycomato® Improves Mitochondrial Function and Delays Cellular Aging

To assess the effectiveness of Lycomato in delaying cellular aging, researchers treated cells with rotenone, a compound that triggers mitochondrial dysfunction. Results showed that when cells were also pre-treated with Lycomato, mitochondrial function improved, mitochondrial ROS levels were reduced by about 70%, ATP levels restored to around 70% and the number of senescent cells was dramatically reduced to near-normal levels. Together, results suggest Lycomato and similar phytonutrient-rich…
PR Newswire
26/09/2024

Sultan bin Ahmed launches Small Hearts and Eyes Campaign at the National…

Sultan bin Ahmedlistened to a detailed explanation from Dr.Ahmed Mohammed Al Kamali, a pediatric heart surgery specialist, about the cases that have undergone surgery, as well as those that will be examined and diagnosed to determine the appropriate type of treatment, whether through catheterization or heart surgery for the sick children. The Chairman of the Sharjah Media Council, learned about the procedures followed in diagnosing medical cases and determining the treatment...
PR Newswire
26/09/2024

Evaxion significantly expands vaccine development collaboration with MSD

Agreement provides MSD with options to license Evaxion's preclinical, AI-designed vaccine candidates EVX-B2 and EVX-B3Evaxion will host a conference call and webcast to discuss the agreement on September 27, 2024COPENHAGEN, Denmark, Sept.26, 2024(GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced that it has entered into an option and license agreement with...
Nasdaq GlobeNewswire
26/09/2024

Johns Hopkins Aramco Healthcare (JHAH) Partners with TruDoc Healthcare to…

Commenting on the initiative Dr. Michael Walsh, CEO, JHAH said, "This initiative represents a pivotal moment in our mission at JHAH to innovate and personalize healthcare. Our expanded telehealth services, launched in 2023, now offers round-the-clock primary care, eliminating barriers such as travel and wait times, and seamlessly integrating into our patients' lives. With this latest advancement, we are enabling patients to transition from hospital to home while maintaining continuous…
PR Newswire
26/09/2024

Orion's collaboration partner Bayer submits application to U.S. FDA for third…

ORION CORPORATIONINVESTOR NEWS26 SEPTEMBER 2024 at 11.00 EEST Orion's collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbuster Orion's collaboration partner Bayer today announced the submission of a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) for the oral androgen receptor inhibitor (ARi) darolutamide. Bayer is seeking approval for...
Nasdaq GlobeNewswire
26/09/2024

AB Science provides an update on the microtubule program AB8939 and in…

PRESS RELEASEAB SCIENCE PROVIDES AN UPDATE ON THE MICROTUBULE PROGRAM AB8939 AND IN PARTICULAR THE ABILITY OF AB8939 TO GENERATE RESPONSE ON MECOM REARRANGEMENTParis, 26 September 2024, 8.30am CETAB Science SA(Euronext - FR0010557264 - AB) today provides an update on the microtubule program AB8939 and in particular the ability of AB8939 to generate response on MECOM rearrangement.AB8939 is a novel microtubule destabilizer currently evaluated in phase 1 clinical trial (study...
Nasdaq GlobeNewswire
26/09/2024

Press Release: Availability of the Q3 2024 Aide mémoire

Availability of the Q3 2024 Aide mémoireParis, France – September 26, 2024. Sanofi announced today that its Q3 2024 Aide mémoire is available on the "Investors" page of the company's website:Third quarter 2024 results (sanofi.com)As for each quarter, Sanofi prepared this document to assist in the financial modelling of the Group's quarterly results. This document includes a reminder on various non-comparable items and exclusivity losses as well as the foreign currency impact and...
Nasdaq GlobeNewswire
26/09/2024
Altri  Comunicati